Acquisition by Stockwell Lynn of 30000 shares of Drugs Made subject to Rule 16b-3
| DMAA Stock | 10.27 0.00 0.00% |
About 56% of Drugs Made's investor base is looking to short. The current sentiment regarding investing in Drugs Made In stock implies that many traders are alarmed. The current market sentiment, together with Drugs Made's historical and current headlines, can help investors time the market. In addition, many technical investors use Drugs Made In stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Drugs Made In Director, 10 Percent Owner, Officer: Ceo And Exe. Chair Of Board. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Drugs Made Fundamental Analysis
We analyze Drugs Made's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Drugs Made using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Drugs Made based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Drugs Made is rated # 3 in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Drugs Made In Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Drugs Made stock to make a market-neutral strategy. Peer analysis of Drugs Made could also be used in its relative valuation, which is a method of valuing Drugs Made by comparing valuation metrics with similar companies.
Peers
Drugs Made Related Equities
| YHNAR | YHN Acquisition | 6.67 | ||||
| VCIC | Vine Hill | 0.48 | ||||
| DTSQ | DT Cloud | 0.1 | ||||
| VACH | Voyager Acquisition | 0.1 | ||||
| NOEMU | CO2 Energy | 0.00 | ||||
| YHNAU | YHN Acquisition | 0.00 | ||||
| DMAA | Drugs Made | 0.00 | ||||
| DRDB | Roman DBDR | 0.1 | ||||
| DMYY | DMY Squared | 0.54 | ||||
| NOEMW | CO2 Energy | 5.56 |
Complementary Tools for Drugs Stock analysis
When running Drugs Made's price analysis, check to measure Drugs Made's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Drugs Made is operating at the current time. Most of Drugs Made's value examination focuses on studying past and present price action to predict the probability of Drugs Made's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Drugs Made's price. Additionally, you may evaluate how the addition of Drugs Made to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |